Actively Recruiting
A Prospective, Global Hip Dysplasia Registry with Follow-up to Skeletal Maturity: Analysis of Risk Factors, Screening Practices, and Treatment Outcomes
Led by University of British Columbia · Updated on 2024-11-18
5000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Developmental dysplasia of the hip (DDH) is the most common hip condition affecting infants and children, involving instability or dislocation of the hip joint's ball-and-socket structure. This can prevent normal hip development and lead to serious problems later in life if untreated. The trial aims to create an international, prospective registry to collect comprehensive data on DDH cases up to age 10, to identify best practices and standardize treatment and management worldwide. The study enrolls patients into three groups based on their treatment status: newly diagnosed patients, those receiving ongoing treatment at participating centers, and those continuing treatment from outside centers. All participants undergo observational data collection without changes to their care. The registry will track outcomes related to screening, diagnosis, bracing, and surgical treatments, with long-term follow-up to skeletal maturity and analysis of treatment timing and risk factors. Participants contribute data through clinical evaluations, imaging such as ultrasound or radiographs, and treatment documentation. Researchers will monitor differences in screening and management protocols, compare treatment outcomes across diagnostic categories, and assess risk factors for complications and future surgeries. The study runs through 2028, collecting data to improve understanding and care of DDH worldwide.
CONDITIONS
Brief Title
Global Hip Dysplasia Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Between the ages of 0 and 10 years at time of initial diagnosis
- Referred for DDH screening due to specific risk factors or diagnosed with DDH
- Diagnosis confirmed with appropriate ultrasonographic or radiographic imaging
You will not qualify if you...
- Known or suspected neuromuscular, collagen, chromosomal, or lower extremity congenital anomalies
- Teratologic hip dislocation (syndromic-associated dislocations)
- Over 10 years of age at initial diagnosis
- Received prior treatment for DDH without appropriate imaging or documentation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to skeletal maturity, until study completion in 2028
Participants who undergo routine care for hip dysplasia are observed over time to collect data on diagnosis, management, and treatment outcomes.
Regular monitoring visits as part of routine clinical care
Trial Site Locations
Total: 1 location
1
British Columbia Children's Hospital
Vancouver, British Columbia, Canada, V6H 3N1
Actively Recruiting
Research Team
E
Emily K Schaeffer, PhD
A
Ashley L Munoz, BSc
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here